Toni K Choueiri

19PUBLICATIONS
104CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersNgā tāngata, te porihanga me ngā hapori o te Māori kāore anō kia whakarōpūtia i wāhi kē (Māori peoples, society and community not elsewhere classified)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|Mar 30, 2026
Cardiac biomarkers in patients with renal cell carcinoma treated with immune checkpoint inhibitors.

Yen-Chou Chen, Mandar A Aras, Brian I Rini

|Mar 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.

Rana R McKay, Archana Ajmera, Michael B Atkins

|Feb 18, 2026
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization.

Douglas B Johnson, Amin H Nassar, Ayesha Aijaz

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Aug 01, 2025
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial.

Brian I Rini, Elizabeth R Plimack, Viktor Stus

Pageof 4

Frequent Collaborators

8 joint publications

Toni K Choueiri

7 joint publications

Michael B Atkins

6 joint publications

Robert Motzer

3 joint publications

Thomas Powles